Want to see TCRX full AI Analyst Report?

TScan Therapeutics (TCRX) Revenue

432 Followers

TScan Therapeutics Revenue

TScan Therapeutics had a revenue of 1.05M in the quarter ending Jun 30, 2026, with 7.03%. This bring the company's revenue in the last twelve months to 7.11M, Increased -22.17%. In the fiscal year ending Dec 31, 2025, TScan Therapeutics had annual revenue of 10.32M with 266.65% growth.

Revenue (ttm)

7.11M

Revenue Growth

2.15%

P/S Ratio

2.08

Revenue/Employee

$74,819

Employees

138

Market Cap

$21.52M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	10.32M	7.51M	+266.65%
Dec 31, 2024	2.82M	-18.23M	-86.62%
Dec 31, 2023	21.05M	7.51M	+55.52%
Dec 31, 2022	13.54M	3.39M	+33.47%
Dec 31, 2021	10.14M	9.06M	+834.65%
Dec 31, 2020	1.08M	―	+∞%
Dec 31, 2019	―	―	―